Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119339) titled 'A Study on the Efficacy and Safety of Oliceridine Fumarate Combined with Remimazolam in Patients Undergoing Painless Abortion' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sichuan Jinxin Xinan Women and Children's Hospital
Condition:
Induced abortion
Intervention:
Oliceridine group:Slow intravenous injection of oliceridine fumarate 0.03 mg/kg
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-02-25
Target Sample Size: Oliceridine group:60;Sufentanil group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/...